<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Neurosci</journal-id><journal-title>BMC Neuroscience</journal-title><issn pub-type="epub">1471-2202</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">15361262</article-id><article-id pub-id-type="pmc">PMC517932</article-id><article-id pub-id-type="publisher-id">1471-2202-5-32</article-id><article-id pub-id-type="doi">10.1186/1471-2202-5-32</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Plasticity of histamine H<sub>3 </sub>receptor expression and binding in the vestibular nuclei after labyrinthectomy in rat</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Lozada</surname><given-names>Adrian F</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>adrian.lozada@abo.fi</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Aarnisalo</surname><given-names>Antti A</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>Antti.Aarnisalo@hus.fi</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Karlstedt</surname><given-names>Kaj</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>kaj.karlstedt@abo.fi</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Stark</surname><given-names>Holger</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>h.stark@pharmchem.uni-frankfurt.de</email></contrib><contrib id="A5" corresp="yes" contrib-type="author"><name><surname>Panula</surname><given-names>Pertti</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I4">4</xref><email>pertti.panula@abo.fi</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Biology, &#x000c5;bo Akademi University, Biocity, Artillerigatan 6A, FIN-20520 Turku, Finland</aff><aff id="I2"><label>2</label>Department of ORL, HUCH, Helsinki, Finland</aff><aff id="I3"><label>3</label>Johann Wolfgang Goethe-Universit&#x000e4;t Frankfurt am Main, Institut f&#x000fc;r Pharmazeutische Chemie, Biozentrum, 60439 Frankfurt am Main, Germany</aff><aff id="I4"><label>4</label>Institute of Biomedicine/Anatomy, POB 63, FIN-00014 University of Helsinki, Finland</aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>10</day><month>9</month><year>2004</year></pub-date><volume>5</volume><fpage>32</fpage><lpage>32</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2202/5/32"/><history><date date-type="received"><day>6</day><month>4</month><year>2004</year></date><date date-type="accepted"><day>10</day><month>9</month><year>2004</year></date></history><copyright-statement>Copyright &#x000a9; 2004 Lozada et al; licensee BioMed Central Ltd.</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license><abstract><sec><title>Background</title><p>In rat, deafferentation of one labyrinth (unilateral labyrinthectomy) results in a characteristic syndrome of ocular and motor postural disorders (e.g., barrel rotation, circling behavior, and spontaneous nystagmus). Behavioral recovery (e.g., diminished symptoms), encompassing 1 week after unilateral labyrinthectomy, has been termed vestibular compensation. Evidence suggesting that the histamine H<sub>3 </sub>receptor plays a key role in vestibular compensation comes from studies indicating that betahistine, a histamine-like drug that acts as both a partial histamine H<sub>1 </sub>receptor agonist and an H<sub>3 </sub>receptor antagonist, can accelerate the process of vestibular compensation.</p></sec><sec><title>Results</title><p>Expression levels for histamine H<sub>3 </sub>receptor (total) as well as three isoforms which display variable lengths of the third intracellular loop of the receptor were analyzed using <italic>in situ </italic>hybridization on brain sections containing the rat medial vestibular nucleus after unilateral labyrinthectomy. We compared these expression levels to H<sub>3 </sub>receptor binding densities.</p><p>Total H<sub>3 </sub>receptor mRNA levels (detected by oligo probe H<sub>3X</sub>) as well as mRNA levels of the three receptor isoforms studied (detected by oligo probes H<sub>3A</sub>, H<sub>3B</sub>, and H<sub>3C</sub>) showed a pattern of increase, which was bilaterally significant at 24 h post-lesion for both H<sub>3X </sub>and H<sub>3C</sub>, followed by significant bilateral decreases in medial vestibular nuclei occurring 48 h (H<sub>3X </sub>and H<sub>3B</sub>) and 1 week post-lesion (H<sub>3A</sub>, H<sub>3B</sub>, and H<sub>3C</sub>). Expression levels of H<sub>3B </sub>was an exception to the forementioned pattern with significant decreases already detected at 24 h post-lesion. Coinciding with the decreasing trends in H<sub>3 </sub>receptor mRNA levels was an observed increase in H<sub>3 </sub>receptor binding densities occurring in the ipsilateral medial vestibular nuclei 48 h post-lesion.</p></sec><sec><title>Conclusion</title><p>Progressive recovery of the resting discharge of the deafferentated medial vestibular nuclei neurons results in functional restoration of the static postural and occulomotor deficits, usually occurring within a time frame of 48 hours in rats. Our data suggests that the H<sub>3</sub> receptor may be an essential part of pre-synaptic mechanisms required for reestablishing resting activities 48 h after unilateral labyrinthectomy.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>In rat, deafferentation of one labyrinth (unilateral labyrinthectomy) results in a characteristic syndrome of ocular motor and postural disorders. These disorders have been divided into two categories : One category of symptoms, called static, includes head rotation in both the frontal and horizontal planes and ocular nystagmus [<xref ref-type="bibr" rid="B1">1</xref>]. The other category, called dynamic, corresponds to a decreased gain of the vestibulo-ocular and vestibulo-spinal refelxes [<xref ref-type="bibr" rid="B1">1</xref>]. Behavioral recovery (e.g., diminished symptoms), encompassing 1 week after unilateral labyrinthectomy, has been termed vestibular compensation [<xref ref-type="bibr" rid="B2">2</xref>]. Moreover, the time course of recovery is very different for static and dynamic reflexes: static deficits disappear in one week but dynamic deficits tend to take several months to normalize. Because unilateral labyrinthectomy results in a permanent loss of vestibular inputs from the lesioned side, the compensatory process is assumed to be attributable to the reorganization of the neural network in the central vestibular system [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Many brain regions including, the medial vestibular nucleus (MVe), are implicated in this process of recovery [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>].</p><p>The focus of our study is the histamine H<sub>3 </sub>receptor that was initially characterized as an autoreceptor controlling histamine synthesis and release [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Subsequently, as a heteroreceptor, the H<sub>3 </sub>receptor was found to mediate presynaptic inhibition of release of histamine, noradrenaline, serotonin, dopamine, glutamate, GABA and tachykinins [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B13">13</xref>], presumably by inhibiting calcium channels [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. The histamine H<sub>3 </sub>receptor was recently cloned from human [<xref ref-type="bibr" rid="B17">17</xref>], monkey [<xref ref-type="bibr" rid="B18">18</xref>], rat [<xref ref-type="bibr" rid="B19">19</xref>], mouse [<xref ref-type="bibr" rid="B20">20</xref>], and guinea pig [<xref ref-type="bibr" rid="B21">21</xref>]. Moreover, the receptor was found to have several isoforms [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B26">26</xref>] with differential coupling to second messenger systems and a variation in their distribution in a region-specific manner. The isoforms are formed by alternative splicing of the messenger RNA (mRNA; [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B24">24</xref>]). This study involves analysis of trends observed in mRNA expression levels for the H<sub>3 </sub>receptor (H<sub>3X</sub>, the oligonucleotide probe detecting all H<sub>3 </sub>receptor mRNAs characterized so far) as well as three of the known functionally active isoforms (H<sub>3A</sub>, H<sub>3B</sub>, and H<sub>3C</sub>), described by Drutel et al. [<xref ref-type="bibr" rid="B24">24</xref>], during the process of post-lesional plasticity in the central nervous system (CNS).</p><p>The primary source of histamine (e.g., ligand for H<sub>3 </sub>receptors) are histaminergic perikarya located exclusively in the tuberomammillary nuclei of the posterior hypothalamus [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]; these same neurons send axonal projections to many areas of the brain including the vestibular nuclear complex in rat [<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B32">32</xref>]. The fact that the rat vestibular nuclear complex is endowed with the H<sub>3 </sub>receptor was established by use of ligand binding [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>] and in situ hybridization methods [<xref ref-type="bibr" rid="B34">34</xref>].</p><p>Evidence suggesting that the H<sub>3 </sub>receptor plays a key role in vestibular compensation comes from studies indicating that betahistine, a histamine-like drug that acts as both a partial histamine H<sub>1 </sub>receptor agonist and an H<sub>3 </sub>receptor antagonist [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B35">35</xref>], accelerates the process of vestibular compensation [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. Furthermore, studies have shown that betahistine treatment results in a reduction of [3H]<italic>N</italic>-&#x003b1;-methylhistamine labelling in the vestibular nuclear complex [<xref ref-type="bibr" rid="B37">37</xref>]; these findings suggest that betahistine increases histamine turnover and release by blocking presynaptic H<sub>3 </sub>receptors and inducing H<sub>3 </sub>receptor downregulation [<xref ref-type="bibr" rid="B37">37</xref>]. It is noteworthy that dynamic vestibular functions can be modulated by H<sub>3 </sub>receptor ligands, e.g., thioperamide [<xref ref-type="bibr" rid="B38">38</xref>]; moreover, thioperamide can affect tonic vestibular functions as well with its demonstrated ability to attenuate barrel rotation in rats following unilateral labyrinthectomy [<xref ref-type="bibr" rid="B39">39</xref>]. The forementioned studies make tenable the view that further elucidation of H<sub>3 </sub>receptor regulation is required to fully understand the process of vestibular compensation.</p><p>The detailed aim of this study was to characterize the patterning of mRNA expression levels for all possible mRNA splice variants of the H<sub>3 </sub>receptor (H<sub>3X</sub>; as described in [<xref ref-type="bibr" rid="B24">24</xref>]) and its isoforms which display different variations of the third intracellular loop (H<sub>3A</sub>, H<sub>3B</sub>, and H<sub>3C</sub>; as described in [<xref ref-type="bibr" rid="B24">24</xref>]) in the medial vestibular nucleus (MVe) during the process of vestibular compensation.</p><p>Moreover, in this study, we compared the aforementioned trend in mRNA expression levels with H<sub>3 </sub>receptor binding densities to reveal the possible plastic changes in the H<sub>3 </sub>receptor which is responsible for significant constitutive activity also <italic>in vivo </italic>[<xref ref-type="bibr" rid="B40">40</xref>], histamine-mediated regulation of neurotransmitter release, and therapeutic effects of betahistine.</p></sec><sec><title>Results</title><sec><title>Expression patterns of total H<sub>3 </sub>receptor and H<sub>3 </sub>receptor isoforms (H<sub>3A</sub>, H<sub>3B</sub>, and H<sub>3C</sub>)</title><p>Changes in mRNA expression levels for H<sub>3 </sub>receptor and the three H<sub>3 </sub>receptor isoforms (Figure <xref ref-type="fig" rid="F1">1A,1B,1C</xref> and <xref ref-type="fig" rid="F1">1D</xref>, respectively) occured bilaterally; that is, there were no significant differences detected between the ipsilateral and contralateral medial vestibular nuclei of animals in all groups studied (e.g., control, 4 h post-lesion, 24 h post-lesion, 48 h post-lesion [n = 4, for each group], and 1 week post-lesion [n = 5]).</p><p>We compared the total H<sub>3 </sub>receptor mRNA expression levels (using probe H<sub>3X</sub>) in ipsilateral MVe of control animals to that of test animals from the four time points (Fig. <xref ref-type="fig" rid="F1">1A</xref>). Fig. <xref ref-type="fig" rid="F2">2B</xref> shows scanned X-ray film depiction of H<sub>3X </sub>expression in a representative animal 24 h post-lesion. We found no significant rise in H<sub>3X </sub>mRNA levels in the ipsilateral MVe 4 hours after lesioning. Significant increases in H<sub>3X </sub>mRNA levels were found to occur at 24 and 48 hours post-lesion. After 1 week post-lesion, H<sub>3 </sub>receptor mRNA expression levels (as indicated by probe H<sub>3X</sub>) returned to normal levels. The trend observed was similar when comparing H<sub>3X </sub>mRNA levels in contralateral MVe of control animals with that of test animals from the four time points. There was no significant change in total H<sub>3 </sub>receptor mRNA levels detected in contralateral MVe 4 hours post-lesion, but we found a significant increase in H<sub>3X </sub>mRNA levels detected in contralateral MVe both 24 hours and 48 hours post-lesion. Finally, a return to normal levels in total H<sub>3X </sub>receptor mRNA level was detected in contralateral MVe 1 week post-lesion.</p><p>No significant increases in H<sub>3A </sub>mRNA expression levels were detected when we compared ipsilateral MVe in control animals with ipsilateral MVe 4 hours, 24 hours, and 48 hours post-lesion (Fig. <xref ref-type="fig" rid="F1">1B</xref>). Fig. <xref ref-type="fig" rid="F2">2D</xref> shows scanned X-ray film depiction of H<sub>3A </sub>expression in a representative animal 24 h post-lesion. On the other hand, a significant decrease of H<sub>3A </sub>mRNA levels does occur in the ipsilateral MVe 1 week after lesioning. The trend was identical when comparing H<sub>3A </sub>mRNA levels in contralateral MVe of control animals with H<sub>3A </sub>mRNA levels in contralateral MVe of animals from the four time points: There was no significant increase in H<sub>3A </sub>mRNA levels when comparing to contralateral MVe 4 hours, 24 hours, and 48 hours post-lesion; on the other hand, there is a significant decrease in H<sub>3A </sub>mRNA levels when comparing to contralateral MVe 1 week after lesioning.</p><p>No significant changes in H<sub>3B </sub>mRNA expression levels were detected when we compared ipsilateral MVe in control animals to ipsilateral MVe 4 hours post-lesion (Fig. <xref ref-type="fig" rid="F1">1C</xref>). Fig. <xref ref-type="fig" rid="F2">2F</xref> shows scanned X-ray film depiction of H<sub>3B </sub>expression in a representative animal 24 h post-lesion. Significant decreases in mRNA levels were found in the ipsilateral MVe 24 hours, 48 hours, and 1 week after lesioning. When comparing contralateral MVe of control animals to contralateral MVe of animals in the other time points, there was a significant increase detected 4 hours post-lesion and this was followed by significant decreases detected at 24 hours, 48 hours after lesion, and 1 week post-lesion.</p><p>No significant changes in H<sub>3C </sub>mRNA levels were detected when we compared ipsilateral MVe in control animals to ipsilateral MVe 4 hours post-lesion (Fig. <xref ref-type="fig" rid="F1">1D</xref>). Fig. <xref ref-type="fig" rid="F2">2H</xref> shows scanned X-ray film depiction of H<sub>3C </sub>expression in a representative animal 24 h post-lesion. A significant increase was detected when comparing ipsilateral MVe of control animals to ipsilateral MVe 24 hours post-lesion; moreover, the decrease in H<sub>3C </sub>mRNA levels in the ipsilateral MVe 48 hours post-lesion was not significantly different from those of the ipsilateral MVe in control animals. Finally, in comparison to the ipsilateral MVe in controls, there was a decrease in mRNA levels that was found to be significant in the ipsilateral MVe 1 week post-lesion. Results were similar when comparing the contralateral MVe in control animals to contralateral MVe from the other time points: There was no significant increase in H<sub>3C </sub>mRNA levels when comparing to contralateral MVe 4 hours post-lesion, there was a significant increase detected when comparing to contralateral MVe 24 hours post-lesion, the decrease was not significant comparing to contralateral MVe 48 hours post-lesion, and a significant decrease was detected when comparing to contralateral MVe 1 week post-lesion.</p></sec><sec><title>[<sup>125</sup>I]iodoproxyfan Binding Densities</title><p>No significant changes were found in H<sub>3 </sub>receptor binding densities (Fig. <xref ref-type="fig" rid="F3">3</xref>) between ipsilateral MVe in control animals (n = 3) and ipsilateral MVe of animals of different time points. The results were identical when H<sub>3 </sub>receptor binding densities in contralateral MVe in control animals were compared to that of contralateral MVe at different times post-lesion. On the other hand, when comparing the ipsilateral to contralateral MVe 48 hours post-lesion, a significant increase in binding densities occurred on the ipsilateral side (Fig. <xref ref-type="fig" rid="F4">4</xref> shows an example of H<sub>3 </sub>receptor binding densities in a representative animal 48 h post-lesion).</p></sec></sec><sec><title>Discussion</title><p>Knowing that there is no reliable method to determine the efficiency of a probe for its targetted sequence in an mRNA of interest, this study focuses instead on the pattern of expression for the total H<sub>3 </sub>receptor (detected by using probe H<sub>3X</sub>) and its isoforms (H<sub>3A</sub>, H<sub>3B</sub>, and H<sub>3C</sub>) occurring during the process of post-lesional plasticity in the CNS. Moreover, the probes used in this study were designed to detect unique areas in the transcripts (H<sub>3A</sub>), or junctional areas in deletion isoforms (probes H<sub>3B </sub>and H<sub>3C</sub>) which would make it highly unlikely for non-specific hybridization would occur. This study also includes a comparison of the aforementioned patterns of expression with binding densities for the H<sub>3 </sub>receptor.</p><p>The prepositus nuclei are delineated and mentioned in legends for figures <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F4">4</xref>. These nuclei are delineated for the sole purpose of giving the reader an idea of the dorsoventral extent of the MVe at the levels depicted in figures <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F4">4</xref>. Noteworthy, is that these nuclei are not included in the main functional projections in the vestibulo-ocular and vestibulo-spinal pathways from the brainstem vestibular nucleus in mammals reviewed by Smith and Curthoys [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>There are three previously described types of neurons in the medial vestibular nucleus [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>]; in vitro, all three types are depolarized by histamine [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>]. Moreover, this depolarization has been shown to be exclusively mediated through postsynaptic H<sub>2 </sub>receptors [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>] suggesting a presynaptic localization of H<sub>3 </sub>receptors in the medial vestibular nuclei [<xref ref-type="bibr" rid="B38">38</xref>]. Consequently, there are three possible locations for H<sub>3 </sub>receptors in the MVe: 1) On the histaminergic or other incoming fibers innervating the MVe [<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B32">32</xref>]. 2) On terminals of the inhibitory interneurons in the MVe that make synaptic contacts on second order excitatory neurons-defined as neurons in the vestibular nuclei that receive inputs from sensory afferents [<xref ref-type="bibr" rid="B45">45</xref>]. 3) On the terminals of second order excitatory MVe neurons making cross-commissural synaptic contacts on contralateral MVe inhibitory interneurons [<xref ref-type="bibr" rid="B45">45</xref>]. With respect to MVe on the lesioned side, an H<sub>3 </sub>receptor mediated inhibition of GABA release from inhibitory interneurons or glutamate release from terminals of second order excitatory MVe neurons may underlie the restoration of resting activity in the deafferentated MVe; more precisely, H<sub>3 </sub>receptor action would result in disinhibition of neurons in the deafferentated MVe</p><p>With respect to the first possible location, it has been established that histamine fibers are endowed with H<sub>3 </sub>receptors that function as autoreceptors and inhibit histamine release [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. Support for the notion that H<sub>3 </sub>receptors are at the next two possible locations (i.e., either at the terminals of the inhibitory interneurons or at the terminals of second order MVe neurons) comes from work showing that betahistine antagonizes the excitatory effect of histamine on vestibular neurons from <italic>in vitro </italic>slice preparations of the dorsal brainstem of the rat [<xref ref-type="bibr" rid="B46">46</xref>]. This finding is significant given that H<sub>3 </sub>receptors mediate presynaptic inhibition of release of other neurotransmitters including: noradrenaline, serotonin, dopamine, glutamate, GABA and tachykinins [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. Unilateral labyrinthectomy induced changes in expression levels of receptors for glutamate (e.g., NR1 and NR2A-D subunits of the NMDA receptor [<xref ref-type="bibr" rid="B47">47</xref>] and GluR2-4 subunits of the AMPA receptor [<xref ref-type="bibr" rid="B48">48</xref>]) have been studied in the vestibular nuclei. Moreover, the existence of both GABA<sub>A </sub>and GABA<sub>B </sub>receptors in the vestibular nuclei and their involvement in vestibular compensation has been demonstrated by either unilateral perfusion or microinjection of GABAergic agonists and antagonists (e.g., GABA, muscimol, and bicuculline) [<xref ref-type="bibr" rid="B49">49</xref>].</p><p>Consequently, an H<sub>3 </sub>receptor antagonist such as betahistine could either facilitate GABA release from inhibitory interneurons located in the MVe that make synaptic contacts with second order neurons or facilitate glutamate release from terminals of second order MVe neurons that synapse on inhibitory interneurons in the contralateral MVe [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B45">45</xref>]. Either scenario would lead to an inhibition of second order neurons in the MVe and this would explain the observation that betahistine antagonizes the excitatory effect of histamine on vestibular neurons [<xref ref-type="bibr" rid="B46">46</xref>].</p><p>On the other hand, betahistine administration is reported to induce recovery with a time benefit of 2 weeks relative to control animals after unilateral vestibular neurectomy [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B36">36</xref>]; this is thought to be due to a bilateral increase in histamine release in the MVe [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. The increased histamine would be bound by H<sub>2 </sub>receptors on the perikarya of MVe neurons ipsilateral and contralateral to the lesion resulting in a bilateral increase in activity. This should facilitate behavioral recovery as it is thought that an imbalance in discharge of MVe neurons (30&#x02013;40 spikes/s in normal animals [<xref ref-type="bibr" rid="B4">4</xref>]) ipsilateral and contralateral to the lesion underlies the static postural and occulomotor deficits triggered by unilateral labyrinthectomy [<xref ref-type="bibr" rid="B45">45</xref>]. Yet, as stated before, the actions of betahistine would also extend to H<sub>3 </sub>receptors located on glutamatergic terminals of contralateral MVe neurons or on GABAergic terminals of inhibitory MVe interneurons. Antagonism of H<sub>3 </sub>receptors at either site may also act to speed recovery by increasing the amount of GABA output from terminals of inhibitory interneurons and, as a consequence, equalizing neuronal discharge activity of ipsilateral and contralateral MVe.</p><p>The trends toward bilateral increases (24 h post-lesion) followed by decreases (48 h post-lesion) in total H<sub>3 </sub>receptor and H<sub>3A</sub>, and H<sub>3C </sub>isoform mRNA levels, with H<sub>3B </sub>mRNA levels already increasing at 4 hours post-lesion and decreasing at 24 h post-lesion, coinciding with a significant increase in H<sub>3 </sub>receptor binding densities in the ipsilateral MVe detected 48 hours post-lesion suggests the occurrence of one or a combination of events in the ipsilateral MVe: 1) an increase in translation has occurred. 2) A change in receptor trafficking between intracellular stores and cell membrane has occurred so that it can be detected as an increase in H<sub>3 </sub>receptor receptor binding densities. In either case, an increase in functional H<sub>3 </sub>receptor protein coupled with an increase in receptor activity may lead to a restoration of resting activity in the deafferentated MVe by scenarios already mentioned in this section.</p></sec><sec><title>Conclusions</title><p>Our findings are significant given that normalization of resting activities in neurons located in the ipsilateral MVe has been shown to occur 48 hours after unilateral labyrinthectomy [<xref ref-type="bibr" rid="B50">50</xref>]. Moreover, by 48 hours post-lesion, commissural disinhibition has been observed to occur [<xref ref-type="bibr" rid="B51">51</xref>]. Placement of H<sub>3 </sub>receptors at the terminals of either GABAergic inhibitory MVe interneurons or on terminals of glutamatergic second order MVe neurons with contralateral projections should result in the observed commissural disinhibition as increased H<sub>3 </sub>receptor activity would result in an inhibition of synaptic release of neurotransmitters.</p><p>Our data would thus suggest that H<sub>3 </sub>receptors are involved in presynaptic mechanisms resulting in a normalization of resting activities in ipsilateral MVe neurons which would balance discharge activity in MVe on both sides.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Animals and surgery</title><p>This study was approved by the Local Committee for Animal Experiments and the Provincial State Office of Western Finland; in addition, animal experiments were in accordance with the European Convention (1986) guidelines and approved by the Animal Ethics Committee of Abo Akademi Unviversity. Adult male Sprague Dawley rats (200&#x02013;250 g) were used. Intraperitoneal (ip) injection of pentobarbital (45 mg/kg ip; Mebunat, Orion, Finland) was used as an anesthetic; in addition, local anesthetic Lidocain (Orion, Finland) was infiltrated under the skin and periosteum prior the procedure. Three steps initiated the surgical procedure to left side of the animal's head: retroauricular skin incision, opening of the middle ear bulla with a drill, and removal of the ossicular chain with the aid of a microscope. Unilateral labyrinthectomy was carried out by opening the horizontal semicircular canal duct in the temporal bone, drilling through the horizontal and anterior semicircular canal ampullae and aspirating the contents of the vestibule. 100% ethanol was injected into the opened labyrinth to finalize the procedure; finally, the wound was sutured. The sham operation entailed opening the middle ear bulla and leaving the ossicular chain intact prior to suturing the wound, as described in Cameron and Dutia [<xref ref-type="bibr" rid="B52">52</xref>]; the control animals (n = 4) that underwent the sham operation were killed 4 h later. The method is explained hereafter. All rats included in the experiments displayed symptoms characteristic of animals that have undergone unilateral labyrinthectomy (e.g., barrel rotation, circling behavior, and spontaneuos nystagmus). These symptoms gadually disappeared during the first two or three days and were completely absent within one week. Animals were stunned by CO<sub>2 </sub>gas and killed by decapitation 4 h (n = 4), 24 h (n = 4), 48 h (n = 4) and 1 week (n = 5) after labyrinthectomy.</p></sec><sec><title>Tissue preparation</title><p>After the mentioned decapitation, brains were removed, frozen in isopentane (-25&#x000b0;C), and stored at -70&#x000b0;C. Tissues were then cut to 20 &#x003bc;m thick cryosections, thaw mounted onto poly-L-lysine coated slides (Menzel-Gl&#x000e4;ser, Germany), and stored at -70&#x000b0;C until used.</p></sec><sec><title>In-situ hybridization histochemistry</title><p>The oligonucleotide probes used for in situ hybridization were designed so that they specifically recognized the different H<sub>3 </sub>receptor isoform mRNAs (H<sub>3A</sub>, H<sub>3B</sub>, and H<sub>3C</sub>; as described in [<xref ref-type="bibr" rid="B24">24</xref>]); an additional oligonucleotide probes was used to detect all characterized H<sub>3 </sub>receptor isoforms (H<sub>3X</sub>; as described in [<xref ref-type="bibr" rid="B24">24</xref>]). Sequences for H<sub>3X</sub>, H<sub>3A</sub>, H<sub>3B</sub>, and H<sub>3C </sub>probes have been previously published [<xref ref-type="bibr" rid="B24">24</xref>]. It is noteworthy that the isoform-specific probes detect selectively the various deletion forms of the third intracellular loop, but do not differentiate between the possible alternative C-termini of the H<sub>3 </sub>receptor isoforms [<xref ref-type="bibr" rid="B53">53</xref>]. However, it has been shown that the differences in the third intracellular loop are significant for coupling to intracellular second messengers [<xref ref-type="bibr" rid="B24">24</xref>]. As a control, we used a normal hybridization mixture with a 100-fold excess of unlabeled specific probes. As an additional control, we used a <italic>Staphylococcus aureus </italic>chloramphenicol acetyltransferase-specific oligonucleotide probe. The hybridization procedure used has been described before and was used with minor modifications [<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B55">55</xref>]. All probes were labeled with [<sup>35</sup>S]deoxyadenosine 5'-&#x003b1;(-thio) triphosphate (New England Nuclear, USA) at their 3' ends using terminal deoxynucleotide transferase (Promega, USA). Nonincorporated nucleotides were removed by purification through Sephadex G-50 columns.</p><p>Before hybridization, cryosections were taken from the -70&#x000b0;C environment and kept at room temeprature for 10 min and treated with UV light for 5 min. The hybridization (10<sup>7</sup>cpm/ml) was carried out at 50&#x000b0;C for 16 to 20 hours in a humidified chamber. Posthybridization washes were carried out as described previously [<xref ref-type="bibr" rid="B55">55</xref>]. Brain sections from control animals and animals 4 h, 24 h, 48 h, and 1 week post-lesion were treated simultaneously with their respective oligonucleotide probe. Sections and carbon-14 standards were exposed to Kodak BioMax X-ray films (Kodak, USA) for 10 days.</p></sec><sec><title>Receptor binding autoradiography</title><p>Autoradiographic localization of [<sup>125</sup>I]iodoproxyfan binding sites has been described before [<xref ref-type="bibr" rid="B56">56</xref>]. Briefly, slide mounted tissue sections were preincubated for 15 min in 50 mM Na<sub>2</sub>HPO<sub>4</sub>-KH<sub>2</sub>PO<sub>4 </sub>phosphate buffer, pH 6.8, containing 0.1% bovine serum albumin and 1 &#x003bc;M S132 (a 1-substituted imidazole derivative displaying a very low affinity at H<sub>3 </sub>receptors and used to decrease non-specific labelling). The sections were then incubated for 1 hour at room temperature in the same buffer containing 15 pM [<sup>125</sup>I]iodoproxyfan (Amersham Pharmacia Biotech UK Limited, England). Non-specific binding was determined by incubating consecutive sections in the presence of 1 &#x003bc;M (R)&#x003b1;-methylhistamine (Sigma-Aldrich, Germany). At the completion of incubation, the tissues were washed four times (4 min each) in the same fresh ice-cold buffer, dipped into ice-cold water, and dried under a current of air. Brain sections from control animals and animals 4 h, 24 h, 48 h, and 1 week post-lesion were treated simultaneously. Dried sections, along with standards, were exposed to Kodak BioMax X-ray films (Kodak, USA) for 2 days.</p></sec><sec><title>Image analysis and statistics</title><p>Autoradiographic films were quantified by digitizing the film images with a computer based MCID 5+ image analysis system (Imaging Research, Canada) and by measuring gray scale pixel values. The relative optic density was converted to integrated optic density (IOD) based on a standard curve derived from standards exposed to films. Gray scale values were determined from four sections for each animal, measurements from white matter of each respective section were subtracted to obtain the final values, and the data were analyzed using either a paired t-test or one-way ANOVA combined with Bonferroni's Multiple Comparison Test as a post-hoc test. Significance was determined when p &#x0003c; 0.05.</p></sec></sec><sec><title>Authors' contributions</title><p>AL assisted with the surgeries and tissue collection, sectioned all of the brains, carried out the <italic>in situ </italic>hybridization and binding studies, performed all of the image and statistical analyses, and participated in the design of the study. AAA performed the surgeries, assisted with tissue collection, assisted with image analyses, and participated in the design of the study. KK established the method of <italic>in situ </italic>hybridization in the lab, designed the oligonucleotide probes, assisted with surgeries and tissue collection, and participated in the design of the study. HS synthesized and supplied rare chemicals required for the binding study. PP acquired funding, coordinated the study, and participated in its design. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>Supported by the Academy of Finland (AFL and PP), Magnus Ehrnrooth's Foundation (AFL), Alcohol Research Foundation (AFL and PP), and Korvatautien tutkimuss&#x000e4;&#x000e4;ti&#x000f6; (AAA)</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisch</surname><given-names>U</given-names></name></person-group><article-title>The vestibular response following unilateral vestibular neurectomy</article-title><source>Acta Otolaryngol</source><year>1973</year><volume>76</volume><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">4542914</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PF</given-names></name><name><surname>Curthoys</surname><given-names>IS</given-names></name></person-group><article-title>Mechanisms of recovery following unilateral labyrinthectomy: a review</article-title><source>Brain Res Rev</source><year>1989</year><volume>14</volume><fpage>155</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">2665890</pub-id><pub-id pub-id-type="doi">10.1016/0165-0173(89)90013-1</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galiana</surname><given-names>HL</given-names></name><name><surname>Flohr</surname><given-names>H</given-names></name><name><surname>Jones</surname><given-names>GM</given-names></name></person-group><article-title>A reevaluation of intervestibular nuclear coupling: its role in vestibular compensation</article-title><source>J Neurophysiol</source><year>1984</year><volume>51</volume><fpage>242</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">6707721</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ris</surname><given-names>L</given-names></name><name><surname>de Waele</surname><given-names>C</given-names></name><name><surname>Serafin</surname><given-names>M</given-names></name><name><surname>Vidal</surname><given-names>PP</given-names></name><name><surname>Godaux</surname><given-names>E</given-names></name></person-group><article-title>Neuronal activity in the ipsilateral vestibular nucleus following unilateral labyrinthectomy in the alert guinea pig</article-title><source>J Neurophysiol</source><year>1995</year><volume>74</volume><fpage>2087</fpage><lpage>2099</lpage><pub-id pub-id-type="pmid">8592199</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>GD</given-names></name><name><surname>Anderson</surname><given-names>JH</given-names></name><name><surname>Beitz</surname><given-names>AJ</given-names></name></person-group><article-title>Brainstem Fos expression following acute unilateral labyrinthectomy in the rat</article-title><source>NeuroReport</source><year>1992</year><volume>3</volume><fpage>829</fpage><lpage>832</lpage><pub-id pub-id-type="pmid">1421082</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cirelli</surname><given-names>C</given-names></name><name><surname>Pompeiano</surname><given-names>M</given-names></name><name><surname>D'Ascanio</surname><given-names>P</given-names></name><name><surname>Arrighi</surname><given-names>P</given-names></name><name><surname>Pompeiano</surname><given-names>O</given-names></name></person-group><article-title><italic>c-fos </italic>expression in the rat brain after unilateral labyrinthectomy and its relation to the uncompensated and compensated stages</article-title><source>Neuroscience</source><year>1996</year><volume>70</volume><fpage>515</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">8848156</pub-id><pub-id pub-id-type="doi">10.1016/0306-4522(95)00369-X</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname><given-names>CD</given-names></name><name><surname>Romero</surname><given-names>GG</given-names></name></person-group><article-title>A role of climbing fibers in regulation of flocculonodular lobe protein kinase C expression during vestibular compensation</article-title><source>Brain Res</source><year>1998</year><volume>804</volume><fpage>253</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">9757058</pub-id><pub-id pub-id-type="doi">10.1016/S0006-8993(98)00658-1</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arrang</surname><given-names>JM</given-names></name><name><surname>Garbarg</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name></person-group><article-title>Autoinhibition of histamine release mediated by a novel class (H<sub>3</sub>) of histamine receptor</article-title><source>Nature</source><year>1983</year><volume>302</volume><fpage>832</fpage><lpage>837</lpage><pub-id pub-id-type="pmid">6188956</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arrang</surname><given-names>JM</given-names></name><name><surname>Garbarg</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name></person-group><article-title>Autoinhibition of histamine synthesis mediated by presynaptic H<sub>3</sub>-receptors</article-title><source>Neuroscience</source><year>1987</year><volume>23</volume><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">2446202</pub-id><pub-id pub-id-type="doi">10.1016/0306-4522(87)90279-X</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schliker</surname><given-names>E</given-names></name><name><surname>Malinowska</surname><given-names>B</given-names></name><name><surname>Kathmann</surname><given-names>M</given-names></name><name><surname>G&#x000f6;thert</surname><given-names>M</given-names></name></person-group><article-title>Modulation of neurotransmitter release via H<sub>3 </sub>heteroreceptors</article-title><source>Fund Clin Pharmacol</source><year>1994</year><volume>8</volume><fpage>128</fpage><lpage>137</lpage></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>SJ</given-names></name><name><surname>Ganellin</surname><given-names>CR</given-names></name><name><surname>Timmerman</surname><given-names>H</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name><name><surname>Shankley</surname><given-names>NP</given-names></name><name><surname>Young</surname><given-names>JM</given-names></name><name><surname>Schunack</surname><given-names>W</given-names></name><name><surname>Levi</surname><given-names>R</given-names></name><name><surname>Haas</surname><given-names>HL</given-names></name></person-group><article-title>International Union of Pharmacology. XIII. Classification of histamine receptors</article-title><source>Pharmacol Rev</source><year>1997</year><volume>49</volume><fpage>253</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">9311023</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>RE</given-names></name><name><surname>Stevens</surname><given-names>DR</given-names></name><name><surname>Haas</surname><given-names>HL</given-names></name></person-group><article-title>The physiology of brain histamine</article-title><source>Prog Neurobiol</source><year>2001</year><volume>63</volume><fpage>637</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">11164999</pub-id><pub-id pub-id-type="doi">10.1016/S0301-0082(00)00039-3</pub-id></citation></ref><ref id="B13"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>JC</given-names></name><name><surname>Arrang</surname><given-names>JM</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Davis KL, Charney D, Coyle JT, Nemeroff C</surname></name></person-group><article-title>Histamine</article-title><source>In Neuropsychopharmacology: The Fifth Generation of Progress</source><year>2002</year><publisher-name>Lippincott Williams and Wilkins, Philadelphia</publisher-name><fpage>179</fpage><lpage>190</lpage></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arrang</surname><given-names>JM</given-names></name><name><surname>Garbarg</surname><given-names>M</given-names></name><name><surname>Quach</surname><given-names>TT</given-names></name><name><surname>Dam Tuong</surname><given-names>M</given-names></name><name><surname>Yaramian</surname><given-names>E</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name></person-group><article-title>Actions of betahistine at histamine receptors in brain</article-title><source>Eur J Pharmacol</source><year>1985</year><volume>111</volume><fpage>73</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">2990946</pub-id><pub-id pub-id-type="doi">10.1016/0014-2999(85)90115-3</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeshita</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Sakata</surname><given-names>T</given-names></name><name><surname>Munakata</surname><given-names>M</given-names></name><name><surname>Ishibashi</surname><given-names>H</given-names></name><name><surname>Akaike</surname><given-names>N</given-names></name></person-group><article-title>Histamine modulates high-voltage-activated clacium channels in neurons dissociated from the rat tuberomammillary nucleus</article-title><source>Neuroscience</source><year>1998</year><volume>87</volume><fpage>797</fpage><lpage>805</lpage><pub-id pub-id-type="pmid">9759967</pub-id><pub-id pub-id-type="doi">10.1016/S0306-4522(98)00152-3</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>RE</given-names></name><name><surname>Haas</surname><given-names>HL</given-names></name></person-group><article-title>On the mechanism of histaminergic inhibition of glutamate release in the rat dentate gyrus</article-title><source>J Physiol</source><year>1999</year><volume>515</volume><fpage>777</fpage><lpage>786</lpage><pub-id pub-id-type="pmid">10066904</pub-id><pub-id pub-id-type="doi">10.1111/j.1469-7793.1999.777ab.x</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lovenberg</surname><given-names>TW</given-names></name><name><surname>Roland</surname><given-names>BL</given-names></name><name><surname>Wilson</surname><given-names>SJ</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Pyati</surname><given-names>J</given-names></name><name><surname>Huvar</surname><given-names>A</given-names></name><name><surname>Jackson</surname><given-names>MR</given-names></name><name><surname>Erlander</surname><given-names>MG</given-names></name></person-group><article-title>Cloning and functional expression of human H<sub>3 </sub>receptor</article-title><source>Mol Pharmacol</source><year>1999</year><volume>55</volume><fpage>1101</fpage><lpage>1107</lpage><pub-id pub-id-type="pmid">10347254</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>BB</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Cassar</surname><given-names>S</given-names></name><name><surname>Esbenshade</surname><given-names>TA</given-names></name><name><surname>Hancock</surname><given-names>AA</given-names></name></person-group><article-title>Cloning and pharmacological characterization of the monkey histamine H3 receptor</article-title><source>Eur J Pharmacol</source><year>2003</year><volume>482</volume><fpage>49</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">14660004</pub-id><pub-id pub-id-type="doi">10.1016/j.ejphar.2003.09.072</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lovenberg</surname><given-names>TW</given-names></name><name><surname>Pyati</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>H</given-names></name><name><surname>Wilson</surname><given-names>SJ</given-names></name><name><surname>Erlander</surname><given-names>MG</given-names></name></person-group><article-title>Cloning of the rat histamine (H<sub>3</sub>) receptor reveals distinct species pharmacological profiles</article-title><source>J Pharmacol Exp Ther</source><year>2000</year><volume>293</volume><fpage>771</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">10869375</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Lovenberg</surname><given-names>TW</given-names></name></person-group><article-title>Molecular and pharmacological characterization of the mouse histamine H3 receptor</article-title><source>Eur J Pharmacol</source><year>2003</year><volume>467</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">12706455</pub-id><pub-id pub-id-type="doi">10.1016/S0014-2999(03)01635-2</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tardivel-Lacombe</surname><given-names>J</given-names></name><name><surname>Rouleau</surname><given-names>A</given-names></name><name><surname>Heron</surname><given-names>A</given-names></name><name><surname>Morisset</surname><given-names>S</given-names></name><name><surname>Pillot</surname><given-names>C</given-names></name><name><surname>Cochois</surname><given-names>V</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name><name><surname>Arrang</surname><given-names>JM</given-names></name></person-group><article-title>Cloning and cerebral expression of the guinea pig histamine H3 receptor: evidence for two isoforms</article-title><source>Neuroreport</source><year>2000</year><volume>11</volume><fpage>755</fpage><lpage>759</lpage><pub-id pub-id-type="pmid">10757514</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wellendorph</surname><given-names>P</given-names></name><name><surname>Goodman</surname><given-names>MW</given-names></name><name><surname>Burstein</surname><given-names>ES</given-names></name><name><surname>Nash</surname><given-names>NR</given-names></name><name><surname>Brann</surname><given-names>MR</given-names></name><name><surname>Weiner</surname><given-names>DM</given-names></name></person-group><article-title>Molecular cloning and pharmacology of functionally distinct isoforms of the human H<sub>3 </sub>receptor</article-title><source>Neuropharmacol</source><year>2002</year><volume>42</volume><fpage>929</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1016/S0028-3908(02)00041-2</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coge</surname><given-names>F</given-names></name><name><surname>Guenin</surname><given-names>SP</given-names></name><name><surname>Audinot</surname><given-names>V</given-names></name><name><surname>Renouard-Try</surname><given-names>A</given-names></name><name><surname>Beauverger</surname><given-names>P</given-names></name><name><surname>Macia</surname><given-names>C</given-names></name><name><surname>Ouvry</surname><given-names>C</given-names></name><name><surname>Nagel</surname><given-names>N</given-names></name><name><surname>Rique</surname><given-names>H</given-names></name><name><surname>Boutin</surname><given-names>JA</given-names></name><name><surname>Galizzi</surname><given-names>JP</given-names></name></person-group><article-title>Genomic organization and characterization of splice variants of the human histamine H<sub>3 </sub>receptor</article-title><source>Biochem J</source><year>2001</year><volume>355</volume><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">11284713</pub-id><pub-id pub-id-type="doi">10.1042/0264-6021:3550279</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drutel</surname><given-names>G</given-names></name><name><surname>Peitsaro</surname><given-names>N</given-names></name><name><surname>Karlstedt</surname><given-names>K</given-names></name><name><surname>Wieland</surname><given-names>K</given-names></name><name><surname>Smit</surname><given-names>MJ</given-names></name><name><surname>Timmerman</surname><given-names>H</given-names></name><name><surname>Panula</surname><given-names>P</given-names></name><name><surname>Leurs</surname><given-names>R</given-names></name></person-group><article-title>Identifcation of rat H<sub>3 </sub>receptor isoforms with different brain expression and signaling properties</article-title><source>Mol Pharm</source><year>2001</year><volume>59</volume><fpage>1</fpage><lpage>8</lpage></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morisset</surname><given-names>S</given-names></name><name><surname>Sasse</surname><given-names>A</given-names></name><name><surname>Gbahou</surname><given-names>F</given-names></name><name><surname>Heron</surname><given-names>A</given-names></name><name><surname>Ligneau</surname><given-names>X</given-names></name><name><surname>Tardivel-Lacombe</surname><given-names>J</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name><name><surname>Arrang</surname><given-names>JM</given-names></name></person-group><article-title>The rat H<sub>3 </sub>receptor: gene organization and multiple isoforms</article-title><source>Biochem Biophys Res Commun</source><year>2001</year><volume>280</volume><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">11162480</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.2000.4073</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weidemann</surname><given-names>P</given-names></name><name><surname>Bonisch</surname><given-names>H</given-names></name><name><surname>Oerters</surname><given-names>F</given-names></name><name><surname>Bruss</surname><given-names>M</given-names></name></person-group><article-title>Structure of the human histamine H<sub>3 </sub>receptor gene (HRH3) and identification of naturally occurring variations</article-title><source>J Neural Transm</source><year>2002</year><volume>109</volume><fpage>443</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">11956964</pub-id><pub-id pub-id-type="doi">10.1007/s007020200036</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panula</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>HYT</given-names></name><name><surname>Costa</surname><given-names>E</given-names></name></person-group><article-title>Histamine-containing neurons in the rat hypothalamus</article-title><source>Proc Natl Acad Sci USA</source><year>1984</year><volume>81</volume><fpage>2572</fpage><lpage>2576</lpage><pub-id pub-id-type="pmid">6371818</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Taguchi</surname><given-names>Y</given-names></name><name><surname>Shiosaka</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>J</given-names></name><name><surname>Kubota</surname><given-names>H</given-names></name><name><surname>Terano</surname><given-names>Y</given-names></name><name><surname>Tohyama</surname><given-names>M</given-names></name><name><surname>Wada</surname><given-names>H</given-names></name></person-group><article-title>Distribution of the histaminergic neuron system in the central nervous system of rats: a flourescent immunohistochemical analysis with histidine decarboxylase as a marker</article-title><source>Brain Res</source><year>1984</year><volume>295</volume><fpage>13</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">6713171</pub-id><pub-id pub-id-type="doi">10.1016/0006-8993(84)90811-4</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panula</surname><given-names>P</given-names></name><name><surname>Pirvola</surname><given-names>U</given-names></name><name><surname>Auvinen</surname><given-names>S</given-names></name><name><surname>Airaksinen</surname><given-names>MS</given-names></name></person-group><article-title>Histamine-immunoreactive nerve fibers in the rat brain</article-title><source>Neuroscience</source><year>1989</year><volume>28</volume><fpage>585</fpage><lpage>610</lpage><pub-id pub-id-type="pmid">2710333</pub-id><pub-id pub-id-type="doi">10.1016/0306-4522(89)90007-9</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steinbusch</surname><given-names>HWM</given-names></name></person-group><article-title>Distribution of histaminergic neurons and fibers in rat brain: comparison with noradrenergic and serotonergic innervation of the vestibular system</article-title><source>Acta Otolaryngol Suppl</source><year>1991</year><volume>479</volume><fpage>12</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">2068936</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Weale</surname><given-names>C</given-names></name><name><surname>Muhlethaler</surname><given-names>M</given-names></name><name><surname>Vidal</surname><given-names>PP</given-names></name></person-group><article-title>Neurochemistry of the central vestibular pathways</article-title><source>Brain Res Brain Res Rev</source><year>1995</year><volume>20</volume><fpage>24</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">7711766</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lacour</surname><given-names>M</given-names></name><name><surname>Tighilet</surname><given-names>B</given-names></name></person-group><article-title>Vestibular compensation in the cat: the role of the histaminergic system</article-title><source>Acta Otolaryngol Suppl</source><year>2000</year><volume>544</volume><fpage>15</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">10904796</pub-id><pub-id pub-id-type="doi">10.1080/000164800750044434</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pollard</surname><given-names>H</given-names></name><name><surname>Moreau</surname><given-names>J</given-names></name><name><surname>Arrang</surname><given-names>JM</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name></person-group><article-title>A detailed autoradiographic mapping of histamine H3 receptos in rat brain areas</article-title><source>Neuroscience</source><year>1993</year><volume>52</volume><fpage>169</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">8381924</pub-id><pub-id pub-id-type="doi">10.1016/0306-4522(93)90191-H</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pillot</surname><given-names>C</given-names></name><name><surname>Heron</surname><given-names>A</given-names></name><name><surname>Cochois</surname><given-names>V</given-names></name><name><surname>Tardivel-Lacombe</surname><given-names>J</given-names></name><name><surname>Ligneau</surname><given-names>X</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name><name><surname>Arrang</surname><given-names>JM</given-names></name></person-group><article-title>A detailed mapping of the histamine H<sub>3 </sub>receptor and its gene transcripts in rat brain</article-title><source>Neuroscience</source><year>2002</year><volume>114</volume><fpage>173</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">12207964</pub-id><pub-id pub-id-type="doi">10.1016/S0306-4522(02)00135-5</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Timmerman</surname><given-names>H</given-names></name></person-group><article-title>Histamine agonists and antagonists</article-title><source>Acta Otolaryngol Suppl</source><year>1991</year><volume>479</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">2068941</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tighilet</surname><given-names>B</given-names></name><name><surname>Leonard</surname><given-names>J</given-names></name><name><surname>Lacour</surname><given-names>M</given-names></name></person-group><article-title>Betahistine dihydrochloride treatment facilitates vestibular compensation in the cat</article-title><source>J Vest Res</source><year>1995</year><volume>5</volume><fpage>53</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/0957-4271(94)00023-U</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tighilet</surname><given-names>B</given-names></name><name><surname>Trottier</surname><given-names>S</given-names></name><name><surname>Mourre</surname><given-names>C</given-names></name><name><surname>Chotard</surname><given-names>C</given-names></name><name><surname>Lacour</surname><given-names>M</given-names></name></person-group><article-title>Betahistine dihydrochloride interaction with the histaminergic system in the cat: neurochemical and molecular mechanisms</article-title><source>Eur J Pharmacol</source><year>2002</year><volume>446</volume><fpage>63</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">12098586</pub-id><pub-id pub-id-type="doi">10.1016/S0014-2999(02)01795-8</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yabe</surname><given-names>T</given-names></name><name><surname>de Waele</surname><given-names>C</given-names></name><name><surname>Serafin</surname><given-names>M</given-names></name><name><surname>Vibert</surname><given-names>N</given-names></name><name><surname>Arrang</surname><given-names>JM</given-names></name><name><surname>Muhlethaler</surname><given-names>M</given-names></name><name><surname>Vidal</surname><given-names>PP</given-names></name></person-group><article-title>Medial vestibular nucleus in the guinea pig histaminergic receptors: II. an in vivo study</article-title><source>Exp Brain Res</source><year>1993</year><volume>93</volume><fpage>249</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">8491265</pub-id><pub-id pub-id-type="doi">10.1007/BF00228392</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>JB</given-names></name><name><surname>O'Neill</surname><given-names>AB</given-names></name><name><surname>Hancock</surname><given-names>AA</given-names></name><name><surname>Sullivan</surname><given-names>JP</given-names></name><name><surname>Brioni</surname><given-names>JD</given-names></name></person-group><article-title>Histaminergic ligands attenuate barrel rotation in rats following unilateral labyrinthectomy</article-title><source>Methods Find Exp Clin Pharmacol</source><year>1998</year><volume>20</volume><fpage>771</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">10022031</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morisset</surname><given-names>S</given-names></name><name><surname>Rouleau</surname><given-names>A</given-names></name><name><surname>Ligneau</surname><given-names>X</given-names></name><name><surname>Gbahou</surname><given-names>F</given-names></name><name><surname>Tardivel-Lacombe</surname><given-names>J</given-names></name><name><surname>Stark</surname><given-names>H</given-names></name><name><surname>Schunack</surname><given-names>W</given-names></name><name><surname>Ganellin</surname><given-names>CR</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name><name><surname>Arrang</surname><given-names>JM</given-names></name></person-group><article-title>High constitutive activity of native H<sub>3 </sub>receptors regulates histamine neurons in brain</article-title><source>Nature</source><year>2000</year><volume>408</volume><fpage>860</fpage><lpage>864</lpage><pub-id pub-id-type="pmid">11130725</pub-id><pub-id pub-id-type="doi">10.1038/35048583</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serafin</surname><given-names>M</given-names></name><name><surname>de Waele</surname><given-names>C</given-names></name><name><surname>Khateb</surname><given-names>A</given-names></name><name><surname>Vidal</surname><given-names>PP</given-names></name><name><surname>Muhlethaler</surname><given-names>M</given-names></name></person-group><article-title>Medial vestibular nucleus in the guinea-pig. I. Intrinsic membrane properties in brainstem slices</article-title><source>Exp Brain Res</source><year>1991</year><volume>84</volume><fpage>417</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">2065749</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serafin</surname><given-names>M</given-names></name><name><surname>de Weale</surname><given-names>C</given-names></name><name><surname>Khateb</surname><given-names>A</given-names></name><name><surname>Vidal</surname><given-names>PP</given-names></name><name><surname>Muhlethaler</surname><given-names>M</given-names></name></person-group><article-title>Medial vestibular nucleus in the guinea-pig. II. Ionic basis of the intrinsic membrane properties in brainstem slices</article-title><source>Exp Brain Res</source><year>1991</year><volume>84</volume><fpage>426</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">1648506</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phelan</surname><given-names>KD</given-names></name><name><surname>Nakamura</surname><given-names>J</given-names></name><name><surname>Gallagher</surname><given-names>JP</given-names></name></person-group><article-title>Histamine depolarizes rat medial vestibular nucleus neurons recorded intracellularly in vitro</article-title><source>Neurosci Lett</source><year>1990</year><volume>109</volume><fpage>287</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">2139500</pub-id><pub-id pub-id-type="doi">10.1016/0304-3940(90)90009-X</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serafin</surname><given-names>M</given-names></name><name><surname>Khateb</surname><given-names>A</given-names></name><name><surname>Vibert</surname><given-names>N</given-names></name><name><surname>Vidal</surname><given-names>PP</given-names></name><name><surname>Muhlethaler</surname><given-names>M</given-names></name></person-group><article-title>Medial vestibular nucleus in the guinea-pig: histaminergic receptors. I. An in vitro study</article-title><source>Exp Brain Res</source><year>1992</year><volume>93</volume><fpage>242</fpage><lpage>248</lpage></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vibert</surname><given-names>N</given-names></name><name><surname>Bantikyan</surname><given-names>A</given-names></name><name><surname>Babalian</surname><given-names>A</given-names></name><name><surname>Serafin</surname><given-names>M</given-names></name><name><surname>Muhlethaler</surname><given-names>M</given-names></name><name><surname>Vidal</surname><given-names>PP</given-names></name></person-group><article-title>Post-lesional plasticity in the central nervous system of the guinea-pig: A "top-down" adaptation process?</article-title><source>Neuroscience</source><year>1999</year><volume>94</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">10613489</pub-id><pub-id pub-id-type="doi">10.1016/S0306-4522(99)00323-1</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Dutia</surname><given-names>MB</given-names></name></person-group><article-title>Effects of histamine and betahistine on rat medial vestibular nucleus neurones: possible mechanism of action of anti-histaminergic drugs in vertigo and motion sickness</article-title><source>Exp Brain Res</source><year>1995</year><volume>105</volume><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">7589314</pub-id><pub-id pub-id-type="doi">10.1007/BF00242178</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sans</surname><given-names>N</given-names></name><name><surname>Sans</surname><given-names>A</given-names></name><name><surname>Raymond</surname><given-names>J</given-names></name></person-group><article-title>Regulation of NMDA receptor subunit mRNA expression in the guinea pig vestibular nuclei following unilateral labyrinthectomy</article-title><source>Eur J Neurosci</source><year>1997</year><volume>9</volume><fpage>2019</fpage><lpage>2034</lpage><pub-id pub-id-type="pmid">9421163</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rabbath</surname><given-names>G</given-names></name><name><surname>Vassias</surname><given-names>I</given-names></name><name><surname>Vidal</surname><given-names>PP</given-names></name><name><surname>de Waele</surname><given-names>C</given-names></name></person-group><article-title>GluR2-R4 AMPA subunit study in rat vestibular nuclei after unilateral labyrinthectomy: an in situ and immunohistochemical study</article-title><source>Neuroscience</source><year>2002</year><volume>111</volume><fpage>189</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">11955722</pub-id><pub-id pub-id-type="doi">10.1016/S0306-4522(01)00569-3</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Waele</surname><given-names>C</given-names></name><name><surname>Muhlethaler</surname><given-names>M</given-names></name><name><surname>Vidal</surname><given-names>PP</given-names></name></person-group><article-title>Neurochemistry of the central vestibular pathways</article-title><source>Brain Res Brain Res Rev</source><year>1995</year><volume>20</volume><fpage>24</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">7711766</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitahara</surname><given-names>T</given-names></name><name><surname>Takeda</surname><given-names>N</given-names></name><name><surname>Kiyama</surname><given-names>H</given-names></name><name><surname>Kubo</surname><given-names>T</given-names></name></person-group><article-title>Molecular mechanisms of vestibular compensation in the central vestibular system-review</article-title><source>Acta Otolaryngol Suppl</source><year>1998</year><volume>539</volume><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">10095856</pub-id><pub-id pub-id-type="doi">10.1080/00016489850182071</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Darlington</surname><given-names>CL</given-names></name><name><surname>Flohr</surname><given-names>H</given-names></name><name><surname>Smith</surname><given-names>PF</given-names></name></person-group><article-title>Molecular mechanisms of brainstem plasticity</article-title><source>Mol Neurobiol</source><year>1991</year><volume>5</volume><fpage>355</fpage><lpage>368</lpage><pub-id pub-id-type="pmid">1668392</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>SA</given-names></name><name><surname>Dutia</surname><given-names>MB</given-names></name></person-group><article-title>Cellular basis of vestibular compensation: changes in intrinsic excitability of MVN neurons</article-title><source>Neuroreport</source><year>1997</year><volume>8</volume><fpage>2595</fpage><lpage>2599</lpage><pub-id pub-id-type="pmid">9261834</pub-id></citation></ref><ref id="B53"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Hough</surname><given-names>LB</given-names></name><name><surname>Leurs</surname><given-names>R</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Pangalos MN, Davies CH</surname></name></person-group><article-title>Histamine receptors</article-title><source>Understanding G protein-coupled receptors and their role in the CNS</source><year>2002</year><publisher-name>Oxford University Press</publisher-name><fpage>307</fpage><lpage>348</lpage></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dagerlind</surname><given-names>A</given-names></name><name><surname>Friberg</surname><given-names>K</given-names></name><name><surname>Bean</surname><given-names>AJ</given-names></name><name><surname>Hokfelt</surname><given-names>T</given-names></name></person-group><article-title>Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry</article-title><source>Histochem</source><year>1992</year><volume>98</volume><fpage>39</fpage><lpage>49</lpage></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lintunen</surname><given-names>M</given-names></name><name><surname>Sallmen</surname><given-names>T</given-names></name><name><surname>Karlstedt</surname><given-names>K</given-names></name><name><surname>Fukui</surname><given-names>H</given-names></name><name><surname>Eriksson</surname><given-names>KS</given-names></name><name><surname>Panula</surname><given-names>P</given-names></name></person-group><article-title>Postnatal expression of H<sub>1</sub>-receptor mRNA in the rat brain: correlation to L-histidine decarboxylase expression and local upregulation in limbic seizures</article-title><source>Eur J Neurosci</source><year>1998</year><volume>10</volume><fpage>2287</fpage><lpage>2301</lpage><pub-id pub-id-type="pmid">9749757</pub-id><pub-id pub-id-type="doi">10.1046/j.1460-9568.1998.00240.x</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ligneau</surname><given-names>X</given-names></name><name><surname>Garbarg</surname><given-names>M</given-names></name><name><surname>Vizuete</surname><given-names>ML</given-names></name><name><surname>Diaz</surname><given-names>J</given-names></name><name><surname>Purand</surname><given-names>K</given-names></name><name><surname>Stark</surname><given-names>H</given-names></name><name><surname>Schunack</surname><given-names>W</given-names></name><name><surname>Schwartz</surname><given-names>JC</given-names></name></person-group><article-title>[<sup>125</sup>I]Iodoproxyfan, a new antagonist to label and visualize cerebral histamine H<sub>3 </sub>receptors</article-title><source>J Pharmacol Exp Ther</source><year>1994</year><volume>271</volume><fpage>452</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">7965746</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>A, B, C, and D &#x02013; Expression levels of the total histamine H<sub>3 </sub>receptor (using probe H<sub>3X</sub>) and its three isoforms (H<sub>3A</sub>, H<sub>3B</sub>, and H<sub>3C</sub>) at 4 h, 24 h, 48 h, and 1 week post-lesion. </bold>Data are presented as mean IOD &#x000b1; SEM. Abbreviations are as follows: ipsi, ipsilateral; contra, contralateral; cntrl, control (n = 4); 4 h, animals sacrificed 4 h post-lesion (n = 4); 48 h, animals sacrificed 48 h post-lesion (n = 4); and 1 wk, animals sacrificed 1 week post-lesion (n = 5). ***p &#x0003c; 0.001 and **p &#x0003c; 0.01 when compared to ipsilateral control. ###p &#x0003c; 0.001, ##p &#x0003c; 0.01, and #p &#x0003c; 0.05 when compared to contralateral control.</p></caption><graphic xlink:href="1471-2202-5-32-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>A) Location of the MVe as visualized on cresyl violet stained section and on x-ray images of parallel sections used in <italic>in situ </italic>hybridization experiments with the various oligonucleotide probes: B) H<sub>3X </sub>C) H<sub>3X </sub>blocking control D) H<sub>3A </sub>E) H<sub>3A </sub>blocking control F) H<sub>3B </sub>G) H<sub>3B </sub>blocking control H) H<sub>3C </sub>I) H<sub>3C </sub>blocking control. </bold>Sections are from a representative animal sacrificed 24 h post-lesion. Abbreviations are as follows: MVe, medial vestibular nucleus and Pr, prepositus nucleus. Scale bars are 100 &#x003bc;m.</p></caption><graphic xlink:href="1471-2202-5-32-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>[<sup>125</sup>I]iodoproxyfan binding densities in MVe of labyrinthectomized rats. </bold>Data are presented as mean IOD &#x000b1; SEM. Abbreviations are as stated in Figure 1 legend. Sample sizes are as follows: control, n = 3; 4 h post-lesion, n = 4; 24 h post-lesion, n = 4; 48 h post-lesion, n = 4; 1 week post-lesion, n = 5. *p = 0.0193.</p></caption><graphic xlink:href="1471-2202-5-32-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>A) Location of the MVe as visualized at high magnification and B) at magnification used in analyses on cresyl violet stained section and C) on x-ray images of parallel sections used in [<sup>125</sup>I]iodoproxyfan binding experiments; D) non-specific binding control is represented in this image. </bold>Sections are from a representative animal sacrificed 48 h post-lesion. Abbreviations are as stated in Figure 2 legend. Scale bars are 100 &#x003bc;m.</p></caption><graphic xlink:href="1471-2202-5-32-4"/></fig></sec></back></article>



